These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2161992)
1. Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity. Hirata Y; Okada K Metabolism; 1990 Jun; 39(6):563-7. PubMed ID: 2161992 [TBL] [Abstract][Full Text] [Related]
2. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats. Hirata Y; Fujimori S; Okada K Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821 [TBL] [Abstract][Full Text] [Related]
3. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819 [TBL] [Abstract][Full Text] [Related]
4. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats. Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179 [TBL] [Abstract][Full Text] [Related]
5. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition. Greene DA; Mackway AM Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804 [TBL] [Abstract][Full Text] [Related]
6. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Gillon KR; Hawthorne JN; Tomlinson DR Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913 [TBL] [Abstract][Full Text] [Related]
7. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats. Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071 [TBL] [Abstract][Full Text] [Related]
8. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Mayer JH; Tomlinson DR Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336 [TBL] [Abstract][Full Text] [Related]
9. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats. Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260 [TBL] [Abstract][Full Text] [Related]
10. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Cameron NE; Cotter MA; Robertson S Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591 [TBL] [Abstract][Full Text] [Related]
11. Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Calcutt NA; Tomlinson DR; Biswas S Diabetes; 1990 Jun; 39(6):663-6. PubMed ID: 2161366 [TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Carrington AL; Ettlinger CB; Calcutt NA; Tomlinson DR Diabetologia; 1991 Jun; 34(6):397-401. PubMed ID: 1653157 [TBL] [Abstract][Full Text] [Related]
13. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors. Sredy J; Flam BR; Sawicki DR Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor. Greene DA; Lattimer SA Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175 [TBL] [Abstract][Full Text] [Related]
15. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats. Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043 [TBL] [Abstract][Full Text] [Related]
16. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol. Greene DA; Chakrabarti S; Lattimer SA; Sima AA J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025 [TBL] [Abstract][Full Text] [Related]
17. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation. Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Stefani MR; Conner CE; Lattimer SA; Kamijo M; Greene DA; Sima AA Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126 [TBL] [Abstract][Full Text] [Related]
18. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition. Cohen MP; Klepser H Diabetes; 1988 May; 37(5):558-62. PubMed ID: 2834250 [TBL] [Abstract][Full Text] [Related]
19. Reduced Na+/K+ adenosine triphosphatase activity and motor nerve conduction velocity in L-fucose-fed rats is reversible after dietary normalization. Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Conner CE Metabolism; 1996 Feb; 45(2):229-34. PubMed ID: 8596495 [TBL] [Abstract][Full Text] [Related]